Clarity and
Confidence

Using Decipher genomic testing to determine where a patient is within the spectrum of risk empowers you in personalizing patient management

Decipher Prostate is Now Covered by Medicare
for ALL Localized Disease

After Biopsy
  • ALL Gleason Scores
  • ALL PSA Values
  • ALL Stages
After Radical Prostatectomy
  • ALL Gleason Scores
  • ALL PSA Values (including undetectable, rising, and persistently elevated PSA)
  • ALL Stages

Decipher Prostate is indicated for non-metastatic men who have not received pelvic radiation or ADT prior to biopsy or RP, and have a life expectancy of 10 years or greater.

Know More With Decipher

Every patient and their prostate cancer is unique, and Decipher genomic testing provides meaningful and independent data to assess the underlying biology and risk of an individual patient’s disease. When used in conjunction with clinical information, Decipher provides clarity and confidence in treatment planning.

View Physician Brochure

Decipher Prostate Covers 7 Cancer Pathways

7 Cancer Pathways

Decipher Prostate was developed from a large cohort of metastatic and non-metastatic prostate cancer patients treated at the Mayo Clinic. The whole transcriptome test utilizes 22 coding and non-coding biomarkers that span seven cancer pathways to provide a more accurate, independent prediction of risk.

Which Decipher Test Should I Order for My Patients?

After Biopsy

Decipher Prostate Biopsy helps determine if patients are suitable for active surveillance, if they need monotherapy, or if they may benefit from multi-modality or intensified therapy.

View Sample Report

After Radical Prostatectomy

Decipher Prostate RP helps determine treatment timing following radical prostatectomy and whether patients undergoing salvage radiotherapy may benefit from the addition of ADT.

View Sample Report

Is Decipher Covered by Medicare and Commercial Insurance?

  • Medicare provides coverage for Decipher for all beneficiaries with localized prostate cancer
  • Many commercial insurance plans provide coverage for Decipher
  • Decipher is committed to providing access to genomic testing for all patients. Financial assistance is available via the Decipher Assist program

Medicare Coverage Decipher Assist

Decipher has been Broadly Validated Across All Localized Disease

Decipher has been validated in 40 studies across 29,876 patients for metastasis, prostate cancer-specific mortality, and overall survival

Ordering the Decipher Prostate Test

Orders can be placed through the physician portal, via email to orders@decipherbio.com, or by fax to 1.858.408.7420

Decipher SM Icons

Please enter your name & email address below to download your PDF:

  • This field is for validation purposes and should be left unchanged.